LORICRIN and Alzheimer disease: Reduced expression of loricrin and involucrin, two cornified-envelope proteins, have been shown in the lesional skin of AD patients, which contributes to the skin barrier defects in AD [108,109], and their expression was also down-regulated by Th2 cytokines [110].